Dexcom Announces Upcoming Conference Presentation
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference:
- Quentin Blackford, Chief Operating Officer and Chief Financial Officer, and Steve Pacelli, Executive Vice President, Strategy and Corporate Development, will present on behalf of the company at the Canaccord Genuity 40th Annual Growth Conference to be held virtually on Wednesday, August 12, 2020 at 9:30am (EST). The presentation will be conducted in two parts and available via live webcast.
Links to the webcasts will be available on the Dexcom Investor Relations website at investors.dexcom.com/ and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200810005558/en/
Dexcom Inc. Aktie
Absolute Beliebtheit: Dexcom Inc. hat nur Buy-Einschätzungen.
Das von der Community festgelegte Kursziel von 122 € für Dexcom Inc. bedeutet eine mögliche Steigerung um über 50% im Vergleich zu 67.72 €.
